Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Peloton Therapeutics, Inc., A Subsidiary Of Merck & Co., Inc. (rahway, New Jersey Usa)

Clinical trials sponsored by Peloton Therapeutics, Inc., A Subsidiary Of Merck & Co., Inc. (rahway, New Jersey Usa), explained in plain language.

Not yet finished but already full! 1

New pill shows promise for rare kidney cancer in VHL patients

Disease control Ongoing

This phase 2 trial is testing a daily pill called belzutifan in 50 people with VHL disease who have kidney cancer. The goal is to see if the drug can shrink tumors. Researchers are also monitoring how long any tumor shrinkage lasts and checking for side effects.

Phase: PHASE2 • Sponsor: Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) • Aim: Disease control

Last updated Jun 22, 2026 11:59 UTC